NWS
60
4
LB
55
2
USB
55
2
MET
66
6
IRM
41
7
SYK
37
2
FTI
46
3
TDC
28
2
DOV
59
2
DLTR
36
-2
WHR
42
2
AVGO
22
4
MHK
40
3
ALL
54
-4
URBN
52
-3
RF
44
3
EQIX
45
3
MCK
74
-4
TXT
46
-2
ECL
47
-7
NWS
60
4
LB
55
2
USB
55
2
MET
66
6
IRM
41
7
SYK
37
2
FTI
46
3
TDC
28
2
DOV
59
2
DLTR
36
-2
WHR
42
2
AVGO
22
4
MHK
40
3
ALL
54
-4
URBN
52
-3
RF
44
3
EQIX
45
3
MCK
74
-4
TXT
46
-2
ECL
47
-7
Financhill
Back

OceanFirst Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
39

OCFC
OceanFirst Financial

Last Price:
$16.78
Seasonality Move:
2.44%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.39
Seasonality Move:
6.73%
Sell
39
OceanFirst Financial (OCFC) is a Sell

Is OceanFirst Financial a Buy, Sell or Hold?

  • The current OceanFirst Financial [OCFC] share price is $16.81. The Score for OCFC is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • OCFC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

OCFC Stock Price Chart

What is OceanFirst Financial's stock price today?

  • The OceanFirst Financial share price today is $16.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCFC is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

OCFC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 37.05 Sell
Chaikin Money Flow: 125226 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.23 - 18.25) Sell
Bollinger Bands (100): (17.58 - 19.88) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

OCFC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.26 Sell
20-day SMA: 17.74 Sell
50-day SMA: 18.02 Sell
200-day SMA: 17.64 Sell
8-day EMA: 17.14 Sell
20-day EMA: 17.55 Sell
50-day EMA: 18.02 Sell
200-day EMA: 17.8 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

OceanFirst Financial Earnings Growth & OCFC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.03 per share, and an increase next year of $0.46 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

OceanFirst Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):